|
" Acrodermatitis continua of Hallopeau response to optimized biological therapy "
Adas, Alanoud; Dadban, Ali; Arnault, Jean-Philippe; Chaby, Guillaume; Lok, Catherine
| Document Type
|
:
|
AL
|
| Record Number
|
:
|
924546
|
| Doc. No
|
:
|
LA93s9w1p3
|
| Language of Document
|
:
|
English
|
| Main Entry
|
:
|
Adas, Alanoud; Dadban, Ali; Arnault, Jean-Philippe; Chaby, Guillaume; Lok, Catherine
|
| Title & Author
|
:
|
Acrodermatitis continua of Hallopeau response to optimized biological therapy [Article]\ Adas, Alanoud; Dadban, Ali; Arnault, Jean-Philippe; Chaby, Guillaume; Lok, Catherine
|
| Title of Periodical
|
:
|
Dermatology Online Journal
|
| Volume/ Issue Number
|
:
|
25/2
|
| Date
|
:
|
2019
|
| Abstract
|
:
|
Acrodermatitis continua of Hallopeau, first described in 1890, is an uncommon variant of pustular psoriasis. It presents as a sterile pustular eruption of the tips of fingers and toes. The condition has a chronic, relapsing course and is often resistant to many anti-psoriatic therapies. In the following case, we present our experience of etanercept use in a 61-year-old man. Although initial therapy with high-dose etanercept achieved a rapid, sustained response and remission, the lesions relapsed a few months into a lower, maintenance dosage. This result prompted the use a second biotherapeutic agent ustekinumab, which resulted in complete remission, but required a higher dosage than recommended with reduced dosing intervals.
|
| |